The US FDA has approved Trulance (plecanatide), from Synergy Pharma, for the treatment of Chronic Idiopathic Constipation (CIC) in adult...
Synergy Pharmaceuticals Inc. announced that the FDA has approved Trulance (plecanatide) 3 mg tablet for the once-daily treatment of irritable...
Bausch Health Companies Inc. announced that it has entered into a definitive agreement to acquire certain assets of Synergy Pharmaceuticals...
Ardelyx, Inc. reported positive results from T3MPO-2, its second Phase III study of tenapanor for irritable bowel syndrome with constipation...
SpecGx LLC, a subsidiary of Mallinckrodt plc that operates its Specialty Generics business, announced that it has received a Complete...
Eisai and Arena Pharmaceuticals have announced that the FDA has accepted for filing the New Drug Application for an extended...